Pfizer Leads Industry-Wide Surge in Drug Prices for 2026 Despite Political Pressure

More than a dozen pharmas have recently struck deals with the White House to lower drug prices. Nevertheless, drugmakers reportedly plan to raise the U.S. prices of at least 350 branded medications.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top